Author

Michelle Weinberg

University of Pennsylvania

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Approach:statistical model· 1

Frequent Co-Authors

Angela R. BradburyiD· 4 shared Brian Lee EglestoniD· 4 shared Cara N. CacioppoiD· 4 shared Dominique FetzeriD· 4 shared Janice Christiansen· 4 shared Linda G. FleisheriD· 4 shared Sarah BrowniD· 4 shared Sarah Howe· 4 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenetic & Genomic Medicine

Angela R. BradburyORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Title: A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocol

Evelyn Mastaglio, Brian Lee Egleston, Kimberley T. Lee, Dominique Fetzer, Sarah Brown, Susan M. Domchek, Linda G. Fleisher, Kuang Yi-Wen, Lynne I. Wagner, Scott Roberts, Cara N. Cacioppo, Janice Christiansen, Sarah Howe, Elisabeth McCarty Wood, Michelle Weinberg, , Angela R. Bradbury

The eREACH2 study evaluates a digital intervention for cancer genetic testing compared to traditional counseling, aiming to improve access and outcomes for at-risk patients.

BMC Cancer · Jul 31, 2026Peer-reviewedGenetic & Genomic Medicine

A Randomized Non-Inferiority Trial of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2)

Kimberley T. Lee, Brian Lee Egleston, Dominique Fetzer, Sarah Brown, Susan M. Domchek, Linda G. Fleisher, Kuang‐Yi Wen, Lynne I. Wagner, J Scott Roberts, Cara N. Cacioppo, Janice Christiansen, Sarah Howe, Elisabeth Wood, Michelle Weinberg, Kelsey Karpink, , eREACH2 Group

eREACH2 evaluates a digital alternative to genetic counseling for cancer genetic testing, finding it non-inferior for service uptake and anxiety but inconclusive for knowledge, with mixed outcomes for result disclosure.

Journal of Clinical Oncology · May 27, 2026Peer-reviewedGenetic & Genomic Medicine

The Next Evolution of Hereditary Cancer Genetic Testing Service Delivery: A Descriptive Study of a Primary Collaborative Care Model for Telegenetics

Daniel Chavez‐Yenter, Kevin Charles Oeffinger, Brian Lee Egleston, Elisabeth McCarty Wood, Sarah Howe, Sarah Brown, Janice Christiansen, Cara N. Cacioppo, Michelle Weinberg, Elena B. Elkin, Linda G. Fleisher, Rajia Mim, Santina Hernandez, Demetrios Ofidis, Dominique Fetzer, , Angela R. Bradbury

This study describes a telegenetics program that collaborates with local providers to improve access to cancer genetic testing, showing high provider participation and willingness to collaborate.

medRxiv · Oct 21, 2025 · PreprintGenetic & Genomic Medicine

eREACH: A randomized trial of digital alternatives to genetic counseling for metastatic cancer

Kimberley T. Lee, Brian Lee Egleston, Briana I. McLeod, Sarah Brown, Sarah Howe, Dominique Fetzer, Susan M. Domchek, Lauren Gutstein, Cara N. Cacioppo, Dana Farengo Clark, Janice Christiansen, Jessica Ebrahimzadeh, Demetrios Ofidis, Hannah Griffin, Rajia Mim, , Angela R. Bradbury

eREACH evaluates digital alternatives to genetic counseling for metastatic cancer patients, finding non-inferiority in short-term outcomes for one GC visit or fully digital models.

medRxiv · Oct 1, 2025 · PreprintGenetic & Genomic Medicine